Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy (INSPIRE) Study

Trial Profile

INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy (INSPIRE) Study

Status: Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 13 Mar 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ketorolac (Primary)
  • Indications Diabetic macular oedema; Diabetic retinopathy
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms INSPIRE
  • Most Recent Events

    • 05 Mar 2024 Status changed from recruiting to active, no longer recruiting.
    • 10 Dec 2020 Status changed from not yet recruiting to recruiting.
    • 09 Sep 2020 Planned initiation date changed from 1 Aug 2020 to 1 Oct 2020.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top